Insulin biosimilar (Valin Technologies)

胰岛素生物类似药 (Valin Technologies)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInsulin biosimilar (Valin Technologies)
Drug Alias Name胰岛素生物仿制药 (Valin Technologies)Van-101
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesValin Technologies
China Registration ClassN/A

Develop Information

Active CompaniesValin Technologies
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A